Apellis Pharmaceuticals general counsel sells $20,518 in stock
David O. Watson, the General Counsel of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), recently sold a portion of his holdings ...
Apellis Pharmaceuticals officer sells shares for $10,776
In a recent transaction involving Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), Mark Jeffrey DeLong, the company's Chief Business & Strategy Officer, sold 365 shares of common stock. The shares were ...